Skip to main content
NIH funding notice RFA-AI-19-059

Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinical Trial Not Allowed)

Closed on January 17, 2020.

Posted
October 11, 2019
Close date
January 17, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,022,423 in first-year total cost, median $989,588.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 AMC-M (S1)]6

Most frequent institutions

  1. SANARIA, INC.2
  2. CAUCASECO SCIENTIFIC RESEARCH CENTER1
  3. SEATTLE CHILDREN'S HOSPITAL1
  4. UNIVERSITY OF SOUTH FLORIDA1
  5. UNIVERSITY OF WASHINGTON1
Competing awards under RFA-AI-19-059 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccines1U01AI155335-01KAPPE, STEFAN HISEATTLE CHILDREN'S HOSPITAL, WA$1,342,548ZAI1
2021Expanding the breadth, magnitude, and durability of PfSPZ vaccines by creating multi-strain vaccines, designer hybrid and genetically altered parasite vaccines and use of a unique adjuvant.1U01AI155356-01SIM, B. KIM LEESANARIA, INC., MD$1,315,127ZAI1
2021Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine1U01AI155361-01ADAMS, JOHN HUNIVERSITY OF SOUTH FLORIDA, FL$1,036,232ZAI1
2021Development of Non-Human Primate Models to Assess Immunological Mechanisms and Antigenic Targets of Protective Sporozoite (SPZ) Vaccines and Establish Superior Efficacy of Next Generation SPZ vaccines1U01AI155354-01HOFFMAN, STEPHEN LEVSANARIA, INC., MD$942,943ZAI1
2021Development of an oral liver-targeted prime-and-trap malaria vaccine1U01AI155313-01MURPHY, SEAN CUNIVERSITY OF WASHINGTON, WA$801,878ZAI1
2021DISCOVERY AND PRECLINICAL DEVELOPMENT OF EFFICACIOUS P. vivax PRE-ERYTHROCYTIC STAGE MALARIA VACCINES1U01AI155363-01HERRERA VALENCIA, SOCRATESCAUCASECO SCIENTIFIC RESEARCH CENTER$583,695ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.